US Codex
C.F.R.
Browse by date
Notes

§812.119. Disqualification of a clinical investigator. — Inbound Citations

21 C.F.R. § 812.119

Cited by 1 regulation in release Current.

Citations to 21 C.F.R. § 812.119 as a whole

  • (c) This part, with the exception of § 812.119, does not apply to investigations of the following categories of devices:
    (1) A device, other than a transitional device, in commercial distribution immediately before May 28, 1976, when used or investigated in accordance with the indications in labeling in effect at that time.
    (2) A device, other than a transitional device, introduced into commercial distribution on or after May 28, 1976, that FDA has determined to be substantially equivalent to a device in commercial distribution immediately before May 28, 1976, and that is used or investigated in accordance with the indications in the labeling FDA reviewed under subpart E of part 807 in determining substantial equivalence.
    (3) A diagnostic device, if the sponsor complies with applicable requirements in § 809.10(c) and if the testing:
    (i) Is noninvasive,
    (ii) Does not require an invasive sampling procedure that presents significant risk,
    (iii) Does not by design or intention introduce energy into a subject, and
    (iv) Is not used as a diagnostic procedure without confirmation of the diagnosis by another, medically established diagnostic product or procedure.
    (4) A device undergoing consumer preference testing, testing of a modification, or testing of a combination of two or more devices in commercial distribution, if the testing is not for the purpose of determining safety or effectiveness and does not put subjects at risk.
    (6) A device shipped solely for research on or with laboratory animals and labeled in accordance with § 812.5(c).
    (7) A custom device as defined in § 812.3(b), unless the device is being used to determine safety or effectiveness for commercial distribution.